HIV incidence among non-pregnant women living in selected rural, semi-rural and Urban areas in Kwazulu-Natal, South Africa

AIDS and Behavior

Volumn 16, Issue 7, 2012, Pages 2062-2071

  Ramjee, Gita ^a   Wand, Handan ^b   Whitaker, Claire ^a   McCormack, Sheena ^c   Padian, Nancy ^d,e   Kelly, Cliff ^f   Nunn, Andrew ^c  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d RTI INTERNATIONAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Cohabitation; HIV; Risk factors; South Africa; Women

Indexed keywords

ADULT; ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTOR; RURAL POPULATION; SEXUAL BEHAVIOR; SOCIOECONOMICS; SOUTH AFRICA; STATISTICS; URBAN POPULATION;

ADULT; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INCIDENCE; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS; RURAL POPULATION; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; SOUTH AFRICA; URBAN POPULATION; YOUNG ADULT;

EID: 84868461802     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-011-0043-7     Document Type: Article

References (46)

1. UNAIDS. Report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS; 2008
2. Chen L, Jha P, Stirling B, et al. Sexual risk factors for HIV infection in early and advanced HIV epidemics in sub-Saharan Africa: systematic overview of 68 epidemiological studies. PLoS One. 2007;2(10):e1001
3. Dunkle K. Transactional sex among women in Soweto, South Africa: prevalence, risk factors and association with HIV infection. Soc Sci Med. 2004;59(8):1581-92
4. Côté A, Sobela F, Dzokoto A, et al. Transactional sex is the driving force in the dynamics of HIV in Accra, Ghana. AIDS. 2004;18(6):917
5. Epstein H. AIDS and the irrational. BMJ. 2008;337:a2638
6. Halperin D, Epstein H. Why is HIV prevalence so severe in southern Africa? The role of multiple concurrent partnerships and lack of male circumcision: implications for AIDS prevention. South Afr J HIV Med. 2007;8:19-25
7. Cohen M, Hoffman I, Royce R, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet. 1997; 349(9069):1868-73
8. Ramjee G, Williams B, Gouws E, Van Dyck E, Deken B, Karim S. The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa. J Acquir Immune Defic Syndr. 2005;39(3):333
9. Weiss H, Quigley M, Hayes R. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. 2000;14(15):2361
10. Siegfried N, Muller M, Deeks J, et al. HIV and male circumcision - a systematic review with assessment of the quality of studies. Lancet Infect Dis. 2005;5(3):165-73
11. Coovadia H, Jewkes R, Barron P, Sanders D, McIntyre D. The health and health system of South Africa: historical roots of current public health challenges. Lancet. 2009;374(9692):817-34
12. Lurie M, Williams B, Zuma K, et al. Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS. 2003;17(15):2245-52
13. Lurie M, Williams B, Zuma K, et al. The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners. Sex Transm Dis. 2003; 30(2):149-56
14. Shisana O, Rehle T, Simbayi LC, et al. South African national HIV prevalence, incidence, behaviour and communication survey 2008: a turning tide among teenagers?. Cape Town: HSRC Press; 2009
15. Department of Health. National antenatal sentinel HIV and syphilis prevalence survey, South Africa. Pretoria: National Department of Health; 2008
16. Ramjee G, Kapiga S, Weiss S, et al. The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials - experience from the HPTN 055 study. J Acquir Immune Defic Syndr. 2008;47(1):93-100
17. Shisana O, Rehle T, Simbayi LC, et al. South African national HIV prevalence, HIV incidence, behaviour and communication survey 2005. Cape Town: HSRC Press; 2005
18. Padian N, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007; 370(9583):251-61
19. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168-74
20. van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL- 1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002;360(9338):971-7
21. Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9654):1977-87
22. Feldblum P, Adeiga A, Bakare R, et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS One. 2008;3(1):e1471
23. van Damme L, Govinden R, Mirembe F, et al. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med. 2008;359(5):463-72
24. Abdool Karim S, Coletti A, Richardson B, et al. Safety and effectiveness of vaginal microbicides BufferGel and 0.5% PRO 2000 gel for the prevention of HIV infection in women: results of the HPTN 035 trial [Abstract 48LB]. 16th Conference on Retroviruses and Opportunistic Infections. Montréal, 8-11 February, 2009
25. McCormack S, Ramjee G, Kamali A, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallelgroup trial. Lancet. 2010;376(9749):1329-37
26. Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses. 2002;18(4):295-307
27. Suligoi B, Massi M, Galli C, et al. Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J Acquir Immune Defic Syndr. 2003;32(4):424-8
28. van de Wijgert J, Braunstein S, Vyankandondera J, et al. Crosssectional estimation of HIV incidence by BED-CEIA and avidity index assays in vaginal microbicide preparedness studies in Rwanda and South Africa [Abstract no. 365]. Pittsburgh: Microbicides 2010; 2010
29. Truong H-HM, Kellogg T, Louie B, Klausner J, Dilley J, McFarland W. Recent HIV-1 infection detection: comparison of incidence estimates derived by laboratory assays and repeat testing data. J Acquir Immune Defic Syndr. 2009;51(4):502-5
30. UNAIDS Reference Group for Estimates MaP Statement on the Use of the BED-Assay for the Estimation of HIV-1 Incidence for Surveillance or Epidemic Monitoring. 2005
31. Brookmeyer R. Measuring the HIV/AIDS epidemic: approaches and challenges. Epidemiol Rev. 2010;32(1):26-37
32. Nunn A, McCormack S, Crook A, Pool R, Rutterford C, Hayes R. Microbicides development programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials. 2009;10(1):99
33. Rehle T, Shisana O, Pillay V, Zuma K, Puren A, Parker W. National HIV incidence measures - new insights into the South African epidemic. S Afr Med J. 2007;97(3):194-9
34. Rehle TM, Hallett TB, Shisana O, et al. A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS One. 2010;5(6):e11094
35. Abdool Karim Q, Kharsany AB, Frohlich JA, et al. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa. Int J Epidemiol. 2010
36. Chigwedere P, Seage GRI, Gruskin S, Lee T-H, Essex M. Estimating the lost benefits of antiretroviral drug use in South Africa. J Acquir Immune Defic Syndr. 2008;49(4):410-5
37. Bärnighausen T, Tanser F, Gqwede Z, Mbizana C, Herbst K, Newell M-L. High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study. AIDS. 2008;22(1):139-44
38. Maharaj P, Cleland J. Condom use within marital and cohabiting partnerships in KwaZulu-Natal, South Africa. Stud Fam Plann. 2004;35(2):116-24
39. Luke N. Age and economic asymmetries in the sexual relationships of adolescent girls in sub-Saharan Africa. Stud Fam Plann. 2003;34(2):67-86
40. Hunter M. The materiality of sex: thinking beyond prostitution. Afr Stud. 2002;61(1):99-120
41. Maharaj P. Patterns of condom use: perspectives of men in KwaZulu-Natal, South Africa. Dev South Afr. 2005;22(2): 187-97
42. Hargreaves J, Glynn J. Educational attainment and HIV-1 infection in developing countries: a systematic review. Trop Med Int Health. 2002;7(6):489-98
43. Lurie M, Pronyk P, de Moor E, et al. Sexual behavior and reproductive health among HIV-infected patients in urban and rural South Africa. J Acquir Immune Defic Syndr. 2008;47(4): 484-93
44. Laga M, Schwärtlander B, Pisani E, Sow PS, Caraël M. To stem HIV in Africa, prevent transmission to young women. AIDS. 2001;15:931-4
45. Greig F, Koopman C. Multilevel analysis of women's empowerment and HIV prevention: quantitative survey results from a preliminary study in Botswana. AIDS Behav. 2003;7(2): 195-208
46. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75(1):3-17